Stock Price Quote

BAL PHARMA LTD.

NSE : BALPHARMABSE : 524824ISIN CODE : INE083D01012Industry : Pharmaceuticals & DrugsHouse : Private
BSE97.10-0.85 (-0.87 %)
PREV CLOSE ( ) 97.95
OPEN PRICE ( ) 100.95
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 8371
TODAY'S LOW / HIGH ( )95.00 100.95
52 WK LOW / HIGH ( )39 137.95
NSE97.10-1.85 (-1.87 %)
PREV CLOSE( ) 98.95
OPEN PRICE ( ) 99.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 44481
TODAY'S LOW / HIGH( ) 94.40 99.85
52 WK LOW / HIGH ( )39 137.7
BSE NSE
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 1987
Management Info
- Chairman Shailesh Siroya - Managing Director
Registered Office

Address 21 & 22,Bommasandra Industrial Area,Hosur Road,
Bengaluru,
Karnataka-560099

Phone +91-080- 27833156

Email --

Website www.balpharma.com

Registrars Details
TSR Darashaw Consultants Pvt Ltd.
C-101, 1st Floor,247 Park, Lal Bahadur Shastri Marg,Vikhroli West,Mumbai
 Listing : BSE, NSE, MCX

NEWS

25May Bal Pharma touches roof on launching F
Bal Pharma is locked its upper circuit limitat Rs. 98.40, up by 4.65 poi..
25May Bal Pharma launches Favipiravir formul
Bal Pharma has launched Favipiravir formulation into Indian market, unde..
24Mar Announcement under Regulation 30 (LOD
Disclosure as per SAST Regulation of SEBI , regarding acquisition of 650..
22Mar Announcement under Regulation 30 (LOD
Disclosure as per Prohibition of Insider Trading Regulations of SEBI...
17Mar Outcome Of The Board Meeting
Pursuant to applicable provisions of Chapter V of SEBI (ICDR) Regulation..
MORE

Financials

in Millions
QTR Dec 20 ANNUAL 20
Net Profit15.4899999999999-95.28
Gross Profit 23.4799999999999 -95.69
Operating Profit 68.699999999999998.74
Net Sales 626.951706.73
MORE

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Procter&Gamble Healt (BSE)
peergroup  5857.25 (1.57%)
M.Cap ( in Cr)9722.67
NGL Fine-Chem (BSE)
peergroup  2112.60 (3.89%)
M.Cap ( in Cr)1305.17
Piramal Enterprises (BSE)
peergroup  2233.90 (3.28%)
M.Cap ( in Cr)50383.00
SMS Lifesciences (BSE)
peergroup  666.80 (6.07%)
M.Cap ( in Cr)201.59
Solara Active Pharma (BSE)
peergroup  1726.00 (1.77%)
M.Cap ( in Cr)6201.48
MORE

Shareholding Pattern

NON-INSTITUTION 55.02%
PROMOTERS 44.98%
MUTUAL FUNDS/UTI 0%
FI/BANKS/INSURANCE 0%
GOVERNMENT 0%
FII 0%
MORE

Mf Holdings

Scheme NameHold(%)
No Data Found

About Bal Pharma Ltd.

Bal Pharma Ltd. was incorporated in the year 1987. Its today's share price is 97.1. Its current market capitalisation stands at Rs 143.93 Cr. In the latest quarter, company has reported Gross Sales of Rs. 1706.73 Cr and Total Income of Rs.1742.88 Cr. The company's management includes Nicloa Neeladri, HS Venkatesh, Himesh Virupakshaya, CV Srinivas, Shailesh Siroya.

It is listed on the BSE with a BSE Code of 524824 , NSE with an NSE Symbol of BALPHARMA and ISIN of INE083D01012. It's Registered office is at 21 & 22,Bommasandra Industrial Area,Hosur RoadBengaluru-560099, Karnataka. Their Registrars are ACC Ltd. It's auditors are NSVM & Associates, TD Jain & DI Sakaria, TD Jain & Dl Sakria

download beyond app
About Nirmal Bang About Nirmal Bang Awards & Accolades Careers at Nirmal Bang Contact Nirmal Bang
Product & Services Equity & Derivatives Trading Forex Trading Commodity Trading Institutional Broking Depository Services Loan Against Securities (LAS) Algo Trading
Equity Price Analysis Volume Analysis Index Analysis News Analysis Corporate Action India Market Other Market Share Market Holidays
Derivatives Updates Market Report Overview
IPO IPO Issues Performance News & Analysis
Commodities Market Movers News & Commentary MCX / NCDEX Holidays
Mutual Funds About Nirmal Bang Niveshalaya Why Associate with Nirmal Bang Mutual Fund Login Mutual Fund Register FAQs Mutual Fund Holidays SIP Calculator Mutual Funds Updates Mutual Funds Trends Mutual Fund Reports Annual Return 2018 Annual Return 2017 Mutual Fund Terms & Conditions Mutual Privacy Policy
Nirmal Bang Research Technical Calls Equity Reports Commodity Reports Currency Research Institutional Research
Nirmal Bang Media Knowledge Center Blog Support Center Become A Partner Beyond Market Careers Sitemap
Other Links Disclaimer Privacy Policy Terms Of Use Rules & Regulations Disclosures Grievances SEBI ScoresRMS Policy
Connect with Us
ATTENTION INVESTORS Depository IPO KYC
Inactive account treatmentNBSPL Policy of AMLNBEPL Policy of AMLNBCPL Policy of AMLNBSPL CSR Policy Physical Settlement Policy of Derivative Aadhar UpdationNirmalbang Privacy Policy V1.0 Documents in Vernacular Languages NBSPL Disclosure Document March 2019
Nirmal Bang Securities Pvt. Ltd. : Member NSE – ID 09391, SEBI Registration No. NSE CM Segment INZ000202536, Member NSE – ID 09391, SEBI Registration No. NSE FO Segment INZ000202536, Member NSE – ID 09391, SEBI Registration No. NSE CDS Segment INZ000202536, Member NSE Commodity – ID 09391, SEBI Registration No. NSE COMMODITY Segment Exchange Registered Broker, Member MSEI – ID 1067, SEBI Registration No. MSEI CM Segment INZ000202536, Member MSEI – ID 1067, SEBI Registration No. MSEI FO Segment INZ000202536, Member MSEI – ID 1067, SEBI Registration No. MSEI CDS Segment INZ000202536, Member MCX – ID 56460, SEBI Registration No. MCX COMMODITY Segment INZ000202536, Member NCDEX – ID 1268, SEBI Registration No. NCDEX COMMODITY Segment NZ000202536, Member ICEX – ID 2073, SEBI Registration No. ICEX COMMODITY Segment INZ000202536, Member BSE – ID 0498, SEBI Registration No. BSE CM Segment INZ000202536, Member BSE – ID 0498, SEBI Registration No. BSE FO Segment INZ000202536, Member BSE – ID 0498, SEBI Registration No. BSE CDS Segment Exchange Registered Broker, Member BSE Commodity – ID 0498, SEBI Registration No. BSE COMMODITY Segment Exchange Registered Broker, SEBI Registration No. PMS INP000002981, SEBI Registration No. Research Analyst INP000002981, SEBI Registration No. DP Participants NSDL – CDSL IN-DP-CDSL 37-99,Member Comtrack Participant Id – ID 50274, Member NERL RP Id– ID R1447, Nirmal Bang Equities Private Limited Member BSE – ID 245, SEBI Registration No. BSE CM Segment INZ000186135, Member NSE – ID 13437, SEBI Registration No. BSE CM Segment INZ000186135, Member NSE – ID 13437, SEBI Registration No. NSE FO Segment INZ000186135, Member NSE Currency – ID 13437, SEBI Registration No. NSE CDS Segment INZ000186135, Member MSEI – ID 17780, SEBI Registration No. MSEI CM Segment INZ000186135, Member MSEI – ID 17780, SEBI Registration No. MSEI FO Segment INZ000186135, SEBI Registration No. Research Analyst Segment INH000001436, Nirmal Bang Commodities Private Limited Member MCX – ID 16590, SEBI Registration No. MCX COMMODITY Segment INZ000043630, Member NCDEX – ID 00362, SEBI Registration No. NCDEX COMMODITY Segment INZ000043630, Member ICEX – ID 1165, SEBI Registration No. ICEX COMMODITY Segment INZ000043630, Member NCDEX Spot Exchange – ID 10084,Comtrack Participant CPID -5040, Participant CDSL Commodity Repository Limited - 12013300
For any grievances, please get in touch on 022-62739390 and write a mail to Contact@nirmalbang.com with Subject line as Grievances/Complain.     |    

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by ●●● Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

AppleApp Store GooglePlay Store
AppleApp StoreGooglePlay Store
Support
Videos